Methylene Blue for Vasoplegic Syndrome after Cardiac Surgery: Early Administration Improves Survival

BACKGROUND: Vasoplegic syndrome, defined by hypotension despite normal or increased cardiac output, is associated with high mortality after cardiopulmonary bypass. Methylene blue (MB) is reported to ameliorate vasoplegic syndrome through the nitric oxide pathway. We hypothesized that early administr...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ann Thorac Surg
Autors principals: Mehaffey, J. Hunter, Johnston, Lily E., Hawkins, Robert B., Charles, Eric J., Yarboro, Leora, Kern, John A., Ailawadi, Gorav, Kron, Irving L., Ghanta, Ravi K.
Format: Artigo
Idioma:Inglês
Publicat: 2017
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5523819/
https://ncbi.nlm.nih.gov/pubmed/28551045
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.athoracsur.2017.02.057
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars